SPC522
Tísótúmab vedótín eða lífefnishliðstæða þar af / Tisotumab vedotin or a biosimilar thereof
Status:
UmsóknApplication date:
11.8.2025Application published:
1.9.2025
Medicine name:
TivdakMedicine for children:
No
Timeline
Today
11.8.2025Application
1.9.2025Publication
Marketing license
IS authorization number:
EU1/125/1911Date:
28.4.2025
Foreign authorization number:
EU/1/25/1911Date:
28.3.2025
Owner
Name:
Genmab A/SAddress:
Carl Jacobsens Vej 30, Valby DK
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2582728